Association of obesity-related inflammatory pathways with lung function and exercise capacity.
暂无分享,去创建一个
B. Medoff | G. Lewis | J. Ho | R. Malhotra | J. Sbarbaro | Emily S Lau | J. McNeill | Emily K. Zern | Elizabeth E. Liu | Robyn Farrell | M. Schoenike | M. Nayor | Rohan R Bhat | Liana C. Brooks | Emily S. Lau | E. Zern | L. Brooks | G. Lewis
[1] V. Regitz-Zagrosek,et al. Sex differences in cardiometabolic disorders , 2019, Nature Medicine.
[2] Kevin McCarthy,et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement , 2019, American journal of respiratory and critical care medicine.
[3] I. Wilkinson,et al. Does Poorer Pulmonary Function Accelerate Arterial Stiffening? , 2019, Hypertension.
[4] R. Naeije,et al. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension. , 2019, Chest.
[5] C. Chuang,et al. Gender- and Age-Specific Associations Between Body Fat Composition and C-Reactive Protein with Lung Function: A Cross-Sectional Study , 2019, Scientific Reports.
[6] A. Lusis,et al. Sex differences in metabolism and cardiometabolic disorders , 2018, Current opinion in lipidology.
[7] A. Dixon,et al. The effect of obesity on lung function , 2018, Expert review of respiratory medicine.
[8] S. Stanojevic,et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement , 2017, American journal of respiratory and critical care medicine.
[9] K. Han,et al. Association between HOMA-IR and Lung Function in Korean Young Adults based on the Korea National Health and Nutrition Examination Survey , 2017, Scientific Reports.
[10] T. Thenappan,et al. Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.
[12] O. Niemelä,et al. Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma , 2016, European Respiratory Journal.
[13] Rajeev Malhotra,et al. Cardiopulmonary Exercise Testing in Heart Failure. , 2016, JACC. Heart failure.
[14] T. Mafort,et al. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function , 2016, Multidisciplinary Respiratory Medicine.
[15] E. K. Weir,et al. The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension. , 2016, Annals of the American Thoracic Society.
[16] J. Paulus,et al. Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction. , 2015, JACC. Heart failure.
[17] N. Leelayuwat,et al. Improvement of pulmonary function with arm swing exercise in patients with type 2 diabetes , 2015, Journal of physical therapy science.
[18] S. Ghio,et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. , 2014, Chest.
[19] K. Mair,et al. Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response , 2014, British journal of pharmacology.
[20] R. Luben,et al. Original Contribution Longitudinal Association of C-Reactive Protein and Lung Function Over 13 Years The EPIC-Norfolk Study , 2013 .
[21] S. Soberanes,et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ. , 2011, American journal of respiratory and critical care medicine.
[22] M. Marmot,et al. Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study , 2011, European Journal of Epidemiology.
[23] R. Simó,et al. Insulin resistance is related to impaired lung function in morbidly obese women: a case–control study , 2010, Diabetes/metabolism research and reviews.
[24] T. Nawrot,et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[25] L. Guize,et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. , 2009, American journal of respiratory and critical care medicine.
[26] J. Pankow,et al. Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes , 2008, Diabetes Care.
[27] I. Kullo,et al. Markers of inflammation are inversely associated with VO2 max in asymptomatic men. , 2007, Journal of applied physiology.
[28] T. McKeever,et al. Systemic inflammation and decline in lung function in a general population: a prospective study , 2007, Thorax.
[29] Jordan T. Shin,et al. Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure , 2006, Circulation.
[30] Craig A. Harms,et al. Does gender affect pulmonary function and exercise capacity? , 2006, Respiratory Physiology & Neurobiology.
[31] D. Postma,et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. , 2006, Respiratory medicine.
[32] Paul Sorajja,et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. , 2006, Journal of the American College of Cardiology.
[33] R. Poulton,et al. C-reactive protein and cardiorespiratory fitness in young adults , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[34] J. Linehan,et al. Distensibility of the normal human lung circulation during exercise. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[35] M. Knuiman,et al. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. , 2004, Diabetes care.
[36] D. Lawlor,et al. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study , 2004, Diabetologia.
[37] J. Kampert,et al. Associations Between Cardiorespiratory Fitness and C-Reactive Protein in Men , 2002, Arteriosclerosis, Thrombosis and Vascular Biology.
[38] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[39] C. Dawson,et al. A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. , 1992, Journal of applied physiology.
[40] A. Sood. Pulmonary Physiology and Pathophysiology in Obesity Obesity , adipokines , and lung disease , 2010 .